Meeting
2019 ASCO Annual Meeting
Impact of time to treatment initiation (TTI) on survival of patients with newly diagnosed non-small cell lung cancer (NSCLC).
Authors
Abdel-Ghani Azzouqa
Mayo Clinic, Jacksonville, FL
Abdel-Ghani Azzouqa , Ruqin Chen , Yanyan Lou , Sikander Ailawadhi , Rami Manochakian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 9058)
DOI
10.1200/JCO.2019.37.15_suppl.9058
Abstract #
9058
Poster Bd #
381
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Population-based impacts of new therapies on outcomes for stage IV non-small cell lung cancer.
First Author: Rebekah Rittberg
Poster
2021 ASCO Annual Meeting
Association of low RKIP expression with poor prognosis in non-small cell lung cancer.
First Author: Lingbin Meng
Poster
2021 Genitourinary Cancers Symposium
Association of survival and local radiotherapy to the bladder versus chemotherapy alone for patients with metastatic urothelial carcinoma (mUC).
First Author: Benjamin Walker Fischer-Valuck
Poster
2019 ASCO Annual Meeting
Updated survival date of phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer.
First Author: Atsushi Horiike